Five High Impact Moves to Maximize Biotech R&D with Limited Resources

Situation

With capital scarce, speed and focus decide who wins. Many teams are spread thin across too many assets and vendors.

Analysis

Five moves consistently unlock momentum:

• Ruthless Pipeline Triage: double down on assets with clear line‑of‑sight to de‑risking milestones.
• Partner Smart + Non‑Dilutive Funding: treat NIH/BARDA/EU calls as a quarterly sprint.
• Tune the CRO Stack: milestone‑based contracts; exit underperformers quickly.
• Shrink Decision Latency: owner‑led micro‑teams; weekly “what’s critical” standups.
• Protect Talent: role clarity, visible wins, flexible work that retains A‑players.

Recommendation

yes I did that already.. like I said, those keys in the screenshot I sent you is from them a week ago.. I already switche

Expected Impact

Fewer delays, higher probability of technical and regulatory success, and a clearer story for investors.

Comment GUIDE for the 1‑page R&D efficiency checklist or DM for a quick review of your operating system.